Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123001434 | 12300143 | 4 | F | 20150903 | 20160630 | 20160425 | 20160712 | EXP | JP-ROCHE-1744296 | ROCHE | 65.74 | YR | F | Y | 49.00000 | KG | 20160712 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123001434 | 12300143 | 1 | PS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 8 | MG/KG | Q3W | |||||||
| 123001434 | 12300143 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous drip | FORM STRENGTH: 420 MG/140 ML | Y | 125409 | 840 | MG | QD | ||||||
| 123001434 | 12300143 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | Y | 0 | 60 | MG/M**2 | Q3W | |||||||
| 123001434 | 12300143 | 4 | C | LOXOPROFEN | LOXOPROFEN | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. | 0 | 180 | MG | ||||||||
| 123001434 | 12300143 | 5 | C | BROTIZOLAM | BROTIZOLAM | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. | 0 | .25 | MG | ||||||||
| 123001434 | 12300143 | 6 | C | TSUMURA GOSHAJINKIGAN | HERBALS | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. | 0 | 7.5 | G | ||||||||
| 123001434 | 12300143 | 7 | C | SLOW-K | POTASSIUM CHLORIDE | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. | 0 | 1200 | MG | ||||||||
| 123001434 | 12300143 | 8 | C | WARFARIN | WARFARIN | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. | 0 | 1.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123001434 | 12300143 | 1 | Breast cancer |
| 123001434 | 12300143 | 2 | Breast cancer |
| 123001434 | 12300143 | 3 | Breast cancer |
| 123001434 | 12300143 | 6 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123001434 | 12300143 | DE |
| 123001434 | 12300143 | LT |
| 123001434 | 12300143 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123001434 | 12300143 | Febrile neutropenia | |
| 123001434 | 12300143 | Intestinal ischaemia | |
| 123001434 | 12300143 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123001434 | 12300143 | 1 | 20150828 | 20150828 | 0 | |
| 123001434 | 12300143 | 2 | 20150828 | 20150828 | 0 | |
| 123001434 | 12300143 | 3 | 20150828 | 20150828 | 0 | |
| 123001434 | 12300143 | 4 | 20150903 | 0 | ||
| 123001434 | 12300143 | 5 | 20150903 | 0 | ||
| 123001434 | 12300143 | 6 | 20150903 | 0 | ||
| 123001434 | 12300143 | 7 | 20150903 | 0 | ||
| 123001434 | 12300143 | 8 | 20150903 | 0 |